Table 2.
Mycobacterial Strains | MIC (µM) | |
---|---|---|
Brassicasterol | Rifampicin | |
Mtb a | 1.9 ± 0.12 | 0.1 ± 0.01 |
Mtb-CI1 b | 2.0 ± 0.13 | 0.2 ± 0.02 |
Mtb-CI2 b | 2.4 ± 0.15 | 0.2 ± 0.03 |
Mtb-CI3 b | 2.2 ± 0.14 | 0.3 ± 0.02 |
Mtb-CI4 b | 2.1 ± 0.14 | 0.3 ± 0.02 |
Mtb-CI5 b | 1.9 ± 0.13 | 0.1 ± 0.02 |
Mtb-CI6 b | 1.9 ± 0.13 | 0.3 ± 0.01 |
Mtb-CI7 b | 2.1 ± 0.14 | 0.2 ± 0.01 |
Mtb-CI8 b | 1.9 ± 0.11 | 0.4 ± 0.03 |
Mtb-CI9 b | 2.1 ± 0.13 | 0.3 ± 0.02 |
Mtb-CI10 b | 2.0 ± 0.15 | 0.1 ± 0.01 |
All recorded values are means ± standard deviation (SD) of three independent experiments assayed in triplicate. a Mtb: Mycobacterium tuberculosis (reference strain; H37Rv CNCTC My 331-88/ATCC 27294); b Mtb: Mycobacterium tuberculosis clinical strains; MIC: minimum inhibitory concentration. All presented data were processed by PRISM software (GraphPad Software, Inc., La Jolla, CA, USA; version 8.0).